Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia

Table 2

Hematological response.

Phase at Diagnosis	No. of patients	Follow-up: No. of patients ()
		CHR	PHR	NHR
Chronic phase	25	13 (52%)	10 (40%)	2 (8%)
Accelerated phase	2	1 (50%)	1 (50%)
Blast Phase	4 (2 died)	1 (50%)	1 (50%)

CHR: complete hematological response, PHR: partial hematological response, and NHR: nil hematological response.